Filing Details
BiomX Inc. (AMEX:PHGE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
The Healthcare company reported Q0 revenue of .
10q filedAMEX:PHGE
BiomX Inc. (PHGE) Files Quarterly Report for Q0
BiomX Inc. (AMEX:PHGE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
At publication ·
What changed
BiomX Inc. (AMEX:PHGE) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- BiomX Inc. (AMEX:PHGE) filed its quarterly report (Form 10-Q) with the SEC on August 19, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $0.14 per share with a market capitalization of $3.7 million as of the filing date.
- The quarterly report includes updates on emerging trends, risk factors, and changes in business conditions since the last annual filing, though specific revenue figures were not disclosed in this summary.
Market Context
BiomX Inc.'s stock currently trades at $0.14 with a market capitalization of $3.7M.
The 10-Q provides BiomX Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for BiomX Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PHGE Stock Page
Frequently Asked Questions
Where can I read PHGE's SEC filings?
Browse all filings on our PHGE SEC filings page.
What types of SEC filings does BiomX Inc. file?
Public companies like BiomX Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.